The aim of our study is to evaluate the relationship between CYP2D6 gene polymorphism and the efficacy of diltiazem, which is used in the acute retarding treatment of patients who present to the emergency department with atrial fibrillation with rapid ventricular response. Here, CYP2D6 is linked to atrial fibrillation.